Dr. Claudio Brunstein, MD
Claim this profileUniversity of Minnesota Masonic Cancer Center
Studies Hematologic Malignancies
Studies Chronic Myeloid Leukemia
4 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Claudio Brunstein, MD is currently running
Umbilical Cord Blood Transplant
for Blood Cancers
For the next 5-10 years or possibly longer, a high proportion of the Cord Blood Banks (CBB) inventory worldwide will be composed of unlicensed umbilical cord blood (UCB) units. While Food and Drug Administration (FDA)-licensed units will be prioritized, it will always be possible that an unlicensed unit will have known attributes, making it a better source of cells for the given indication. Because of the wide variety of current and potential indications as a source of cells for hematopoietic reconstitution or other form of cellular therapy, it is critical that the investigators have access to unlicensed UCB units.
Recruiting1 award N/A
Cord Blood Transplant
for Leukemia
This is a treatment guideline for an unrelated umbilical cord blood transplant (UCBT) using a myeloablative preparative regimen for the treatment of hematological diseases, including, but not limited to acute leukemias. The myeloablative preparative regimen will consist of cyclophosphamide (CY), fludarabine (FLU) and fractionated total body irradiation (TBI).
Recruiting3 awards N/A4 criteria
More about Claudio Brunstein, MD
Clinical Trial Related14 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Claudio Brunstein, MD has experience with
- Cyclophosphamide
- Fludarabine
- Infusion Of Cell Populations From Unlicensed Umbilical Cord Blood Units
- Total Body Irradiation
- Omidubicel
- Sirolimus
Breakdown of trials Claudio Brunstein, MD has run
Hematologic Malignancies
Chronic Myeloid Leukemia
Leukemia
Burkitt Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Claudio Brunstein, MD specialize in?
Claudio Brunstein, MD focuses on Hematologic Malignancies and Chronic Myeloid Leukemia. In particular, much of their work with Hematologic Malignancies has involved treating patients, or patients who are undergoing treatment.
Is Claudio Brunstein, MD currently recruiting for clinical trials?
Yes, Claudio Brunstein, MD is currently recruiting for 2 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Claudio Brunstein, MD has studied deeply?
Yes, Claudio Brunstein, MD has studied treatments such as Cyclophosphamide, Fludarabine, Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units.
What is the best way to schedule an appointment with Claudio Brunstein, MD?
Apply for one of the trials that Claudio Brunstein, MD is conducting.
What is the office address of Claudio Brunstein, MD?
The office of Claudio Brunstein, MD is located at: University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455 United States. This is the address for their practice at the University of Minnesota Masonic Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.